Products & Programs PharmacyAnthem Blue Cross and Blue Shield | Medicare AdvantageJanuary 18, 2024

RETRACTED: Expansion of specialty pharmacy precertification list

This article was published in error and retracted on February 23, 2024. Please access the updated version here.

Effective for dates of service on and after May 1, 2024, the specialty Medicare Part B drugs listed in the table below will be included in our precertification review process.

Federal and state law, as well as state contract language and CMS guidelines (including definitions and specific contract provisions/exclusions), take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims.

HCPCS or CPT® codes

Medicare Part B drugs

J3490, J3590, J9999, C9399

Elrexfio (elranatamab-bcmm)

J3490, J3590

Eylea HD (aflibercept)

J3490, J3590

Pombiliti (cipaglucosidase alfa-atga)

J3490, J3590, J9999, C9399

Talvey (talquetamab-tgvs)

J3490, J3590

Tyruko (natalizumab-sztn)

J3590, C9399

Veopoz (pozelimab-bbfg)

J3490

Ycanth (cantharidin)

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Maine, Inc. Independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MEBCBS-CR-046710-23-CPN45768

PUBLICATIONS: February 2024 Provider Newsletter